Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT07112950
Eligibility Criteria:
Inclusion Criteria:
* Patients with a confirmed diagnosis of lung cancer through histopathology or radiology.
* Lung cancer patients aged over 18 years.
* Stage III-IV lung cancer patients receiving therapy at Dr. Cipto Mangunkusumo National General Hospital (RSUPN) and Tangerang District General Hospital (RSUD Kabupaten Tangerang).
* Patients with a VAS score \>10 mm for baseline pain and \>40 mm during breakthrough pain.
* Willing to participate in the study until completion by signing the informed consent form.
Exclusion Criteria:
* Lung cancer patients with deteriorating general condition.
* Presence of wounds or infections at the press needle insertion site.
* History of allergy to stainless steel materials.
* Patients with blood clotting disorders: platelet count \<50,000/μL, ANC \<1000/mm³, or patients undergoing anticoagulant therapy with INR \>2.142.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07112950
Study Brief:
Protocol Section:
NCT07112950